Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer.

Saved in:
Bibliographic Details
Title: Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer.
Authors: Foroughi O; Health Advances LLC, Newton, MA 02466, USA., Madraswala S; Health Advances LLC, Newton, MA 02466, USA., Hayes J; AstraZeneca, Gaithersburg, MD 20878, USA., Glover K; AstraZeneca, Gaithersburg, MD 20878, USA., Lee L; AstraZeneca, Gaithersburg, MD 20878, USA.; Merck & Co., Inc., Rahway, NJ 07065, USA., Chaki M; AstraZeneca, Gaithersburg, MD 20878, USA., Redpath S; AstraZeneca, Gaithersburg, MD 20878, USA., Yu AW; Merck & Co., Inc., Rahway, NJ 07065, USA., Chiu D; Merck & Co., Inc., Rahway, NJ 07065, USA., Amanti KG; Health Advances LLC, Newton, MA 02466, USA., Gustavsen G; Health Advances LLC, Newton, MA 02466, USA.
Source: Journal of personalized medicine [J Pers Med] 2023 Aug 03; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 03.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37623478
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Foroughi+O%22">Foroughi O</searchLink>; Health Advances LLC, Newton, MA 02466, USA.<br /><searchLink fieldCode="AU" term="%22Madraswala+S%22">Madraswala S</searchLink>; Health Advances LLC, Newton, MA 02466, USA.<br /><searchLink fieldCode="AU" term="%22Hayes+J%22">Hayes J</searchLink>; AstraZeneca, Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Glover+K%22">Glover K</searchLink>; AstraZeneca, Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Lee+L%22">Lee L</searchLink>; AstraZeneca, Gaithersburg, MD 20878, USA.; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Chaki+M%22">Chaki M</searchLink>; AstraZeneca, Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Redpath+S%22">Redpath S</searchLink>; AstraZeneca, Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Yu+AW%22">Yu AW</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Chiu+D%22">Chiu D</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Amanti+KG%22">Amanti KG</searchLink>; Health Advances LLC, Newton, MA 02466, USA.<br /><searchLink fieldCode="AU" term="%22Gustavsen+G%22">Gustavsen G</searchLink>; Health Advances LLC, Newton, MA 02466, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101602269%22">Journal of personalized medicine</searchLink> [J Pers Med] 2023 Aug 03; Vol. 13 (8). <i>Date of Electronic Publication: </i>2023 Aug 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101602269 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2075-4426 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220754426%22">20754426 </searchLink><i>NLM ISO Abbreviation: </i>J Pers Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37623478
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/jpm13081228
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Foroughi O
      – PersonEntity:
          Name:
            NameFull: Madraswala S
      – PersonEntity:
          Name:
            NameFull: Hayes J
      – PersonEntity:
          Name:
            NameFull: Glover K
      – PersonEntity:
          Name:
            NameFull: Lee L
      – PersonEntity:
          Name:
            NameFull: Chaki M
      – PersonEntity:
          Name:
            NameFull: Redpath S
      – PersonEntity:
          Name:
            NameFull: Yu AW
      – PersonEntity:
          Name:
            NameFull: Chiu D
      – PersonEntity:
          Name:
            NameFull: Amanti KG
      – PersonEntity:
          Name:
            NameFull: Gustavsen G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 08
              Text: 2023 Aug 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2075-4426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Journal of personalized medicine
              Type: main
ResultId 1